Helix Pharma (Pvt.) Ltd.

Helix Pharma Private Limited is a Pakistan based pharmaceutical company incorporated in the year 1960, member of the Hakimsons Group established since 1921, principally engaged in the manufacture of life saving drugs. A technical collaboration in 1965 with Takeda Pharmaceutical Company of Japan was forged to build a world class pharmaceutical factory. The group’s journey in the last 100 years has been one that has gone through many political and economic cycles and has stood witness to the scientific evolution in medicine as well as very dramatic change in the regulations that primarily govern the pharmaceutical industry. Adapting to these changes has been a key factor in our success, as has been the ability to remodel our operations to best meet the needs of the medical community. Our commitment to preserving the environment and our support to local communities through health and educational initiatives affords us an opportunity to give back society in the spirit of compassion and shared human values. In order to reduce our carbon foot print we are in the process of converting 80% of the electricity needs of all our industrial and commercial facilities to renewable energy. In the next seven years we anticipate our complete fleet of vehicles will go electric. Several government registered local charities are recipients of our grant that include hospitals, school, blood banks and other special interest initiatives. Pharmaceuticals Portfolio: In addition to an extensive range of branded generics that cover 75% of all therapeutic classes and products manufactured under license, we have a range of imported biological and oncology drugs. Herbals / Nutraceuticals: Our range of nutraceutical/herbal proprietary formulations has been developed, tested and marketed with an aim to capture the growing and promising area of Alternative Medicine. Investing in the right direction is essential for a sustainable tomorrow...

Mundipharma

Mundipharma is a global healthcare company with a presence across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East. Mundipharma is dedicated to bringing innovative treatments to patients in the areas of Pain Management, Infectious Disease and Consumer Healthcare as well as other severe and debilitating disease areas. Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do. We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work. For more information visit www.mundipharma.com See our community guidelines: mundipharma.com/social-media-community-guidelines

Fagron

Fagron is committed to the personalization of health treatment to cover the individual patient’s need through Pharmaceutical Compounding & Sterile Outsourcing Services. Pharmaceutical Compounding allows pharmacists and prescribers to create medication that satisfies patients’ needs. Through our services towards personalization, we can extend the range of mass-produced medication and keep available medicaments that are no longer offered commercially in an affordable way for those who need them. Fagron was founded in the Netherlands in 1990 and is currently present in 35 countries worldwide enabling pharmacists, prescribers, hospitals, and industry to provide quality, safety, and service for their patients. Together we create the future of personalizing medicine.

msd nederland

MSD – zorgen voor gezondheid Je gezondheid heeft aandacht nodig. Bescherming en zorg. Samen met zorgverleners, beleidsmakers en verzekeraars zijn wij er om je daarmee te steunen. Wij zijn MSD. We bieden patiënten én zorgverleners innovatieve geneesmiddelen die het verschil kunnen maken tussen ziek op bed liggen én de gewone, dagelijkse dingen doen. Soms zelfs tussen leven en dood. Wij zijn actief op tal van gebieden. En zoeken continu nieuwe oplossingen voor ziektes waar nog geen antwoord op is. Altijd met aandacht voor de juiste patiënt op het juiste moment. We ontwikkelen ook slimme oplossingen om medicatie optimaal in te zetten. Zodat we mensen helpen en tegelijkertijd verspilling tegengaan. Waardoor geneesmiddelen effectiever, veiliger én doelmatiger gebruikt kunnen worden. We zoeken actief de samenwerking en dialoog met partners in de zorg om toekomstbestendige zorg te realiseren die aansluit bij de gezamenlijke behoefte. Door onze geneesmiddelen en oplossingen op maat maken wij het mogelijk om jullie waarde propositie richting andere zorgpartners te optimaliseren. Zo zorgen we samen voor de gezondheid van miljoenen mensen in Nederland. Want onze gezondheid is het meest dierbare wat er is. Wij zijn MSD. Wij zorgen voor gezondheid. Samen met jou.

Centrient Pharmaceuticals

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.